| GI3 |
|
Headline : GI Imaging
Date : Wednesday, 04 November 2026
Start Time : 08:30
End Time : 10:30
Location : Main Hall
|
|
|
|
Presentations |
|
08:30 - 00:00
|
LI-RADS Treatment Response: How To Report HCC Viability After Locoregional Therapies (Ablation/TACE).
Faeze Salahshour |
|
08:50 - 00:00
|
Borderline Lesions In The Cirrhotic Liver: Imaging The Stepwise Carcinogenesis. Distinguishing Regenerative Nodules Vs. Dysplastic Nodules Vs. Early HCC.
Pooneh Dehghan |
|
09:15 - 00:00
|
Intrahepatic Cholangiocarcinoma: Differentiating Mass-forming CCA From HCC And Mixed HCC-CCA, Staging Pearls
Niloofar Ayoubi Yazdi |
|
09:40 - 00:00
|
Liver Metastases: Assessing "treatment Response" Post-chemotherapy And The Concept Of Pseudocirrhosis
Mohammad Reza Ayoubpour |
|
10:00 - 00:00
|
Interventional Management Of Hepatic Metastases: A Guide For Patient Selection And Interventional Procedure
Alireza Rasekhi |
|
10:20 - 00:00
|
Q&A
|
